Filgrastim Clinical Trials

• Filgrastim Compared With Filgrastim-SD/01 Following Combination Chemotherapy in Treating Patients With Newly Diagnosed Sarcoma
  ClinicalTrials.gov Identifier: NCT00020137 - Active, not recruiting
  Cardiac Toxicity; Neutropenia; Sarcoma
  
• Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors
  ClinicalTrials.gov Identifier: NCT00115128 - Active, not recruiting
  Healthy
  
• Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00003294 - Active, not recruiting
  Leukemia; Lymphoma
  
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00014456 - Active, not recruiting
  Cancer
  
• Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002836 - Active, not recruiting
  recurrent breast cancer
  
• Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts after Intensive Chemotherapy
  ClinicalTrials.gov Identifier: NCT00004853 - Recruiting
  Ewing's Sarcoma; Rhabdomyosarcoma; Sarcoma; Synovial Sarcoma
  
• Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00008125 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00032149 - Active, not recruiting
  AIDS-Related Lymphoma
  
• Combination Chemotherapy and Filgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00031629 - Active, not recruiting
  recurrent uterine sarcoma; uterine leiomyosarcoma
  
• Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer
  ClinicalTrials.gov Identifier: NCT00019474 - Active, not recruiting
  Pancreatic Cancer; Gastric Cancer; adult primary liver cancer
  
• Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00030758 - Active, not recruiting
  Neutropenia; stage I breast cancer; stage II breast cancer
  
• Epoetin alfa With or Without Filgrastim Compared With Blood Transfusions in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003138 - Active, not recruiting
  Anemia; Myelodysplastic Syndromes; Quality of Life
  
• Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
  ClinicalTrials.gov Identifier: NCT00005930 - Recruiting
  Hematopoietic Stem Cell Mobilization
  
• Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
  ClinicalTrials.gov Identifier: NCT00003929 - Active, not recruiting
  AIDS-related primary CNS lymphoma; primary central nervous system lymphoma
  
• Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004172 - Active, not recruiting
  stage IIIB breast cancer; stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer
  
• Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00004066 - Active, not recruiting
  adult soft tissue sarcoma; ovarian sarcoma; small intestine cancer; uterine sarcoma
  
• Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002833 - Active, not recruiting
  Chronic Myelogenous Leukemia; Graft vs Host Disease; Philadelphia chromosome; Myeloid Leukemia; Refractory Anemia; Chronic Myelomonocytic Leukemia
  
• Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00041067 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005985 - Active, not recruiting
  Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; Non-Hodgkin's Lymphoma
  
• Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004157 - Active, not recruiting
  Testicular Cancer; ovarian epithelial cancer; Lymphoma; Breast Cancer; kidney tumor
  
• Pegfilgrastim Compared With Filgrastim To Increase Peripheral Stem Cells Before Autologous Stem Cell Transplantation in Treating Patients With Lymphoma
  ClinicalTrials.gov Identifier: NCT00060229 - Active, not recruiting
  adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma; Cutaneous T-Cell Lymphoma
  
• Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma
  ClinicalTrials.gov Identifier: NCT00101127 - Active, not recruiting
  recurrent uterine sarcoma; stage III uterine sarcoma; stage IV uterine sarcoma; uterine leiomyosarcoma
  
• Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00028717 - Active, not recruiting
  adult diffuse large cell lymphoma; adult non-Hodgkin's lymphoma; grade 3 follicular lymphoma; Mantle Cell Lymphoma
  
• Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00005863 - Active, not recruiting
  Acute Myeloid Leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; childhood acute monocytic leukemia; ...
  
• Docetaxel and Gemcitabine with Filgrastim-SD/01 Support in Patients with Advanced Non-Small Cell Lung Carcinoma
  ClinicalTrials.gov Identifier: NCT00050674 - Recruiting
  Non-small cell lung cancer
  
• Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00007904 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer
  
• Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00006263 - Active, not recruiting
  adult brain stem glioma; adult glioblastoma multiforme; high-grade childhood cerebral astrocytoma; adult anaplastic astrocytoma; ...
  
• Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer
  ClinicalTrials.gov Identifier: NCT00021333 - Active, not recruiting
  Lung Cancer; Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Thyroid Cancer; Oropharyngeal Cancer
  
• Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00053131 - Active, not recruiting
  recurrent adult acute myeloid leukemia; recurrent childhood acute myeloid leukemia; recurrent adult acute lymphoblastic leukemia; ...
  
• Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00016406 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; inflammatory breast cancer
  
• Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00004215 - Active, not recruiting
  Anemia; adult acute poorly differentiated monocytic leukemia (M5a); adult acute myeloblastic leukemia with maturation (M2); ...
  
• Chemotherapy in Treating Patients With Retinoblastoma
  ClinicalTrials.gov Identifier: NCT00002675 - Active, not recruiting
  Retinoblastoma
  
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer
  ClinicalTrials.gov Identifier: NCT00005958 - Active, not recruiting
  stage III bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; transitional cell carcinoma of the bladder; ...
  
• Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors
  ClinicalTrials.gov Identifier: NCT00005796 - Active, not recruiting
  Brain Tumor
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00004114 - Active, not recruiting
  Leukemia; Lymphoma
  
• Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006215 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004192 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003397 - Active, not recruiting
  Lymphoma
  
• Pegfilgrastim Versus Filgrastim After High-Dose Chemotherapy
  ClinicalTrials.gov Identifier: NCT00410696 - Recruiting
  Hematological Neoplasms; Tumors
  
• Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00004898 - Active, not recruiting
  Leukemia; Lymphoma
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002740 - Active, not recruiting
  disseminated neuroblastoma
  
• Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002501 - Active, not recruiting
  stage IV grade II follicular mixed cell lymphoma; recurrent grade I follicular small cleaved cell lymphoma; ...
  
• Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00207792 - Recruiting
  Graft vs Host Disease
  
• Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated Donors
  ClinicalTrials.gov Identifier: NCT00511550 - Recruiting
  Healthy
  
• Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003398 - Active, not recruiting
  Lymphoma; Leukemia; Multiple Myeloma
  
• Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma
  ClinicalTrials.gov Identifier: NCT00003187 - Active, not recruiting
  Lymphoma; Leukemia
  
• Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00004061 - Active, not recruiting
  Leukemia; Lymphoma
  
• Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00005946 - Active, not recruiting
  Leukemia; Lymphoma
  
• Peripheral Stem Cell Transplantation With Donor White Blood Cells in Treating Older Patients With Hematologic Cancers
  ClinicalTrials.gov Identifier: NCT00003196 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
  ClinicalTrials.gov Identifier: NCT00003573 - Active, not recruiting
  untreated childhood medulloblastoma
  
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003270 - Active, not recruiting
  Lymphoma; Leukemia; Multiple Myeloma
  
• Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas
  ClinicalTrials.gov Identifier: NCT00003113 - Active, not recruiting
  Lymphoma
  
• Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
  ClinicalTrials.gov Identifier: NCT00039130 - Recruiting
  L3 adult acute lymphoblastic leukemia; adult Burkitt's lymphoma; untreated adult acute lymphoblastic leukemia
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma
  ClinicalTrials.gov Identifier: NCT00002601 - Active, not recruiting
  Bone Cancer; Soft Tissue Sarcoma
  
• Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus
  ClinicalTrials.gov Identifier: NCT00010413 - Active, not recruiting
  Pemphigus
  
• Combination Chemotherapy Plus Rituximab and Filgrastim in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00018980 - Recruiting
  Lymphoma
  
• Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial
  ClinicalTrials.gov Identifier: NCT00041470 - Active, not recruiting
  Breast Cancer
  
• High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002784 - Active, not recruiting
  Breast Cancer
  
• Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant
  ClinicalTrials.gov Identifier: NCT00005852 - Active, not recruiting
  Lymphoma; Multiple Myeloma; Leukemia
  
• Tumor Cell Vaccine in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00002505 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002532 - Active, not recruiting
  recurrent adult acute lymphoblastic leukemia
  
• Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00023777 - Active, not recruiting
  Myeloid Leukemia
  
• Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma
  ClinicalTrials.gov Identifier: NCT00002539 - Active, not recruiting
  localized osteosarcoma
  
• Cyclophosphamide and Filgrastim Followed By Peripheral Stem Cell Transplantation in Treating Patients With Chronic or Accelerated Phase Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00005984 - Recruiting
  chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ...
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00002831 - Active, not recruiting
  Leukemia, Myeloid; Leukemia, Myeloid, Chronic
  
• Phase I Study of Retrovirus-Mediated Transfer of cDNA for Human CD18 into Peripheral Blood Repopulating Cells of Patients With Leukocyte Adherence Deficiency
  ClinicalTrials.gov Identifier: NCT00004470 - Active, not recruiting
  Leukocyte Adhesion Deficiency Syndrome
  
• Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00012298 - Recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma; indolent, adult non-Hodgkin's lymphoma; marginal zone lymphoma; ...
  
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002461 - Active, not recruiting
  Lymphocytic Lymphoma; Hodgkin's Disease; Non-Hodgkin's Lymphoma
  
• Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer
  ClinicalTrials.gov Identifier: NCT00014573 - Active, not recruiting
  Brain Tumor
  
• Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003597 - Active, not recruiting
  Brain Tumors; Musculoskeletal Tumors; Kidney Tumors; Solid Tumors
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004906 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
  ClinicalTrials.gov Identifier: NCT00003632 - Active, not recruiting
  primary central nervous system lymphoma
  
• Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005959 - Active, not recruiting
  Lymphoma
  
• High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003392 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003032 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00053768 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
  ClinicalTrials.gov Identifier: NCT00007813 - Active, not recruiting
  childhood liver cancer; Bone Cancer; Testicular Cancer; Brain Tumor
  
• High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002837 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003877 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00030719 - Recruiting
  regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003860 - Active, not recruiting
  extensive stage small cell lung cancer
  
• Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002868 - Active, not recruiting
  chronic phase chronic myelogenous leukemia
  
• Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00004048 - Active, not recruiting
  medullary thyroid cancer
  
• TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002757 - Active, not recruiting
  Burkitt's Lymphoma; Lymphoblastic Leukemia; Lymphocytic Lymphoma
  
• Pegfilgrastim Vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-Lymphoma
  ClinicalTrials.gov Identifier: NCT00306111 - Recruiting
  Non-Hodgkin Lymphoma
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00017355 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Combination Chemotherapy in Treating Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003088 - Active, not recruiting
  stage IIIA breast cancer; stage II breast cancer
  
• Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002755 - Active, not recruiting
  stage IIIA breast cancer; stage II breast cancer
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00012311 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002628 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003812 - Active, not recruiting
  limited stage small cell lung cancer
  
• Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003288 - Active, not recruiting
  unspecified childhood solid tumor, protocol specific
  
• High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002870 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; Quality of Life
  
• Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
  ClinicalTrials.gov Identifier: NCT00006734 - Active, not recruiting
  localized tumors of the Ewing's family
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003972 - Active, not recruiting
  stage IIIA breast cancer; stage II breast cancer
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003136 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002680 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
  
• Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002634 - Active, not recruiting
  disseminated neuroblastoma; regional neuroblastoma; localized resectable neuroblastoma; recurrent neuroblastoma; localized unresectable neuroblastoma
  
• Combination Chemotherapy With or Without Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00003027 - Active, not recruiting
  Stage IV Melanoma
  
• Combination Chemotherapy in Treating Patients With Lymphoma
  ClinicalTrials.gov Identifier: NCT00002835 - Active, not recruiting
  Lymphoma